Patents and other intellectual property litigation
Taylor Wessing is the pre-eminent force in IP litigation in Europe - both nationally in the UK, Germany and France and also centrally before the European Patent Office, European Court of Justice and International Court of Arbitration.
The firm is instructed in most leading IP cases, particularly those in the life science sectors, and this experience makes us highly qualified to control and co-ordinate complex and high profile multijurisdictional litigation throughout Europe.
Furthermore, many of the lawyers in the group have scientific backgrounds, qualifications or industrial experience, reinforcing our ability to provide the best possible representation for our clients in relation to the full spectrum of related issues.
Recent (and pending) IP cases which the group has handled involve disputes relating to:
- Paroxetine
- Sildenafil
- Seretide
- Erythropoietin
- Alendronate
- Glucagon-like peptide 1
- medical devices for treating brain aneurysms
- X-ray collimating technology
- clinical assessment software.
We place great importance on our ability to offer our clients valuable strategic advice which helps them to realise their longer-term goals, including the registration and exploitation of technical property rights and the protection of expertise and know-how.
In particular, we are highly experienced in assisting young companies to develop sustainable patent strategies and conclude agreements for research and development or licensing arrangements. Thanks to our track record in this field, our clients seek and appreciate our advice on matters of cooperation between biotech or pharmaceutical companies and hospitals.